Jubilant Pharmova Announces 48th AGM and Dividend

Company Disclosure

Jubilant Pharmova Limited (Scrip Code: 530019, NSE Symbol: JUBLPHARMA) has made a regulatory filing pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Publication Details

The advertisements were published in:

• Financial Express (All Editions - English language)
• Hindustan (Hindi language)
• Jansatta (Hindi language)

Key Information Disclosed

• The company completed email dissemination of the Notice of the 48th Annual General Meeting and the Annual Report for the Financial Year 2025-26 to members whose email IDs are registered with the Company/Depositories on Saturday, August 1, 2026.
• The notice includes information about e-voting procedures for the Annual General Meeting.
• The notice contains information regarding a final dividend declaration.